: Coronavirus: Dr Reddy’s announces commercial launch of oral drug 2-DG, priced at Rs 990 #IndiaNEWS Pharmaceutical company Dr Reddy’s Laboratories on Monday announced the commercial launch of oral

@IndiaNEWS

Posted in: #IndiaNEWS

Coronavirus: Dr Reddy’s announces commercial launch of oral drug 2-DG, priced at Rs 990 #IndiaNEWS
Pharmaceutical company Dr Reddy’s Laboratories on Monday announced the commercial launch of oral anti-coronavirus drug 2-deoxy-D-glucose, or 2-DG. The Defence Research and Development Organisation has developed the drug in collaboration with Dr Reddy’s.In a statement, the pharmaceutical firm said that it will supply the drug to governments and private hospitals, beginning with metro and tier-1 cities. The coverage will subsequently be expanded across the country, it said.The company has fixed the price of the drug at Rs 990 but will sell them to government institutions at a subsidised rate. “2-DG is yet another addition to our Covid-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and includes a vaccine,� Satish Reddy, the chairperson of Dr Reddy’s said. “We are extremely pleased to have partnered with DRDO in our collective fight against the Covid-19 pandemic.�On May 1, the Drugs Controller General of India had given approval for emergency use to 2-DG for the treatment of moderate to severe coronavirus patients. The Ministry of Defence had said the drug developed from the molecule 2-deoxy-D-glucose, also called 2-DG, has been permitted to be used as an adjunct therapy. This means that 2-DG can be used along with the primary treatment given to Covid-19...Read more

Intraday stocks under 50 NSE India Twitter of India

Vote Up Vote Down

Login to post a comment!